DividendChannel.com
ABBV Dividend History & Description — AbbVie Inc

AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.

Name: 
AbbVie Inc
Stock buyback: 
ABBV buyback
Website: 
www.abbvie.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding ABBV: 
119 (see which ones)
Total Market Value Held by ETFs: 
$23,345,195,132.54
Total Market Capitalization: 
$209,777,000,000
% of Market Cap. Held by ETFs: 
11.13%
Name:  AbbVie Inc
Stock buyback:  ABBV buyback
Website:  www.abbvie.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding ABBV:  119 (see which ones)
Total Market Value Held by ETFs:  $23,345,195,132.54
Total Market Capitalization:  $209,777,000,000
% of Market Cap. Held by ETFs:  11.13%

ABBV Next Earnings Date »
ABBV Next Dividend Date »
(Projection based upon history)
Quotes delayed 20 minutes
Email EnvelopeFree ABBV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


Buy (3.42 out of 4)
47th percentile
(ranked lower than approx. 53% of all stocks covered)

Analysts' Target Price:
ABBV Forecast

Based on data provided by Zacks Investment Research via Quandl.com

Forum posts »



 

ABBV | AbbVie Inc | Dividend History | Dividend Channel | www.DividendChannel.com

Copyright © 2010 - 2021, All Rights Reserved Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.